title: Severe and common side-effects of amphotericin B lipid complex (Abelcet)
authors.forename: O
authors.initials: O
authors.lastname: Ringdén
authors.forename: V
authors.initials: V
authors.lastname: Jønsson
authors.forename: M
authors.initials: M
authors.lastname: Hansen
authors.forename: J
authors.initials: J
authors.lastname: Tollemar
authors.forename: N
authors.initials: N
authors.lastname: Jacobsen
mesh_terms: D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000009:adverse effects* / Q000627:therapeutic use; D000935:Antifungal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006402:Hematologic Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010713:Phosphatidylcholines / Q000009:adverse effects* / Q000627:therapeutic use; D010715:Phosphatidylglycerols / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000935:Antifungal Agents; D004338:Drug Combinations; D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; C068538:liposomal amphotericin B; D000666:Amphotericin B